Novel medications for epilepsy.


Despite the introduction of many second-generation antiepileptic drugs (AEDs) in the last 2 decades, the proportion of individuals with pharmacoresistant epilepsy has not been reduced substantially compared with the late 1960s. All currently available AEDs also have limitations in terms of adverse effects and susceptibility to be involved in clinically… (More)
DOI: 10.2165/11594640-000000000-00000


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics